Last Price$8.75NASDAQ Previous Close - Last Trade as of 1:48PM ET 8/11/22

Today's Change-0.12(1.35%)
Bid (Size)N/A (N/A)
Ask (Size)N/A (N/A)
Day Low / High$8.65 - 8.98
Volume8.3 K

View Biotechnology IndustryPeer Comparison as of 08/11/2022


ImmuCell Corp ( NASDAQ )

Price: $8.75
Change: -0.12 (1.35%)
Volume: 8.3 K
1:48PM ET 8/11/2022

9 Meters Biopharma Inc ( NASDAQ )

Price: $0.26
Change: -0.0004 (0.15%)
Volume: 2.0 M
4:00PM ET 8/11/2022

Synlogic Inc ( NASDAQ )

Price: $1.09
Change: +0.11 (11.22%)
Volume: 300.00
4:00PM ET 8/11/2022

Avalon Globocare Corp ( NASDAQ )

Price: $0.69
Change: +0.01 (2.06%)
Volume: 110.9 K
3:59PM ET 8/11/2022

UNITY Biotechnology Inc ( NASDAQ )

Price: $0.85
Change: -0.12 (12.36%)
Volume: 2.8 K
4:00PM ET 8/11/2022

Read more news Recent News

ImmuCell Says FDA is Requiring Re-Inspection of Manufacturing Facility for Dairy Cattle Medication
4:29AM ET 7/28/2022 MT Newswires

ImmuCell (ICCC) said Wednesday that the US Food and Drug Administration has required the re-inspection of the manufacturing facility for dairy cattle...

After Hours Watch List Scorecard: ICCC, XMTR, HOTH
5:15PM ET 4/12/2022 MT Newswires

Here's how the stocks on Monday's After Hours Watch List performed during today's regular session: AFTER HOURS REGULAR SESSION ICCC +9.4% ...

MT Newswires After Hours Watch List: ICCC, XMTR, HOTH
5:42PM ET 4/11/2022 MT Newswires

Here are some of the stocks moving in after-hours trading worth watching in Tuesday's regular session: ICCC: +9.4%; Sees Q1 revenue up 46% from year ago;...

ImmuCell Sees Q1 Revenue Up 46% from Year Ago
4:36PM ET 4/11/2022 MT Newswires

ImmuCell (ICCC) said Monday it expects revenue of $6.0 million in Q1, up 46% from a year ago. "This favorable comparison does reflect tighter supply...

Company Profile

Business DescriptionImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kit and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME. View company web site for more details
Address56 Evergreen Drive
Portland, Maine 04103
Number of Employees51
Recent SEC Filing08/11/20228-K
President, CEO, CFO, Secretary & TreasurerMichael F. Brigham
Director-Product DevelopmentJohn W. Zinckgraf
Director, Vice President-Sales & MarketingBobbi Jo Brockmann
Vice President-Manufacturing OperationsElizabeth L. Williams

Company Highlights

Price Open$8.98
Previous Close$8.75
52 Week Range$7.30 - 10.96
Market Capitalization$67.7 M
Shares Outstanding7.7 M
SectorHealth Technology
Next Earnings Announcement08/11/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings64.14
Earnings per Share$0.12
Beta vs. S&P 500N/A
Revenue$11.0 M
Net Profit Margin4.53%
Return on Equity2.93%

Analyst Ratings as of 07/10/2020

Consensus RecommendationConsensus Icon
Powered by Factset